FDA clearance for Binax Bacterial Meningitis
Binax have announced an additional cleared application for the patented Streptococcus pneumoniae Antigen Test.
The test can be used on CSF for the detection of bacterial meningitis caused by S. pneumoniae
Binax recently announced an exclusive distribution partnership with Remel Inc to provide rapid tests to hospital and clinical reference laboratories in the USA.
NOTE: This item is from our 'historic' database and may contain information which is not up to date.
Source : Binax, Inc. [USA]
Now part of Alere, Inc View Company Information
Posted on December 15, 2001
Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- How an EMS Can Help You Meet Annex 1
- Is Your Environmental Monitoring In Line With The New Annex 1?
- Improved R-CARD® Yeast and Mold Ideally Suited for Monitoring Mold Hazard in Premises
- Annex 1: Will You Be Ready? - a rapidmicrobiology Special Focus
- Guidelines for the Manufacturing of Sterile Medicinal Products
- Microbiologics Custom Environmental Isolate Controls
- Microbial Monitoring Solutions for Sterile Medicinal Product Manufacturing Environments
- Stericheck® - Universal Operator Broth Transfer Validation Pack
- Does Plate Choice Change Sampling Accuracy?
- Red One™: Rapid Sterility Results in 4 days
MICROBIOLOGY EVENTS
- Visit MWE at Medlab Middle East
- Medlab Middle East
- Microbiology for non microbiologists
- HypoxEU Virtual Seminar
- Using VITAL Reference Doses for Allergen Labelling
- GENAP Summit 2023
- 2023 PDA Annex 1 Workshop
- 7th Microbiome Movement - AgBioTech Summit
- Viable Air and Surface Sampling for Sterile Compounding Facilities
- Low Endotoxin Recovery/Masking - Hands-on Laboratory Training Course